EX-99.1 2 c47600exv99w1.htm EX-99.1 EX-99.1
Exhibit 99.1
(PREGIS COMPANY LOGO)  
Press Release
For Immediate Release
Contacts:
Keith LaVanway
847-597-9353
klavanway@pregis.com
Leslie Braun
847-597-9328
lbraun@pregis.com
PREGIS ANNOUNCES THIRD QUARTER 2008 FINANCIAL RESULTS
Deerfield, IL, November 13, 2008 — Pregis Corporation, a leading international manufacturer, marketer, and supplier of protective packaging products and specialty packaging solutions, today announced its financial results for the third quarter of 2008.
The Company’s net sales in the third quarter were $265.2 million, an increase of 8.2% over net sales of $245.2 million in the third quarter of 2007. Excluding the impact of favorable foreign currency translation and sales from an acquisition made in the fourth quarter of 2007, the quarter’s net sales increased 2.5% compared to the prior year quarter.
Gross profit margin, as a percent of net sales, was 22.4% in the third quarter of 2008, compared to 23.1% in the third quarter of 2007. The decline in gross margin was primarily due to significantly increased costs of resin, fuel and other raw materials in the 2008 period. According to the CMAI indices, resin costs in the U.S. and Europe increased approximately 31% and 17%, respectively, in the third quarter of 2008 compared to the third quarter of 2007. The third quarter gross margin percentage improved 100-basis points compared to the gross profit margin of 21.4% in the second quarter of 2008, reflecting the impact of selling price increases implemented during the quarter as well as the impact of continued cost reduction initiatives.
For the third quarter of 2008, operating income was $10.1 million compared to $10.4 million in the third quarter of 2007, with the reduction driven primarily by pre-tax severance charges totaling $5.2 million relating to the Company’s various productivity and cost reduction programs. The third quarter pre-tax severance charges include $3.9 million relating to the Eerbeek, Netherlands plant closure previously announced.
Commenting on the Company’s results for the third quarter, Mike McDonnell, President and Chief Executive Officer, stated, “Overall, we are pleased with the results we achieved in the third quarter. We made good progress with our pricing actions in the quarter; however, we have yet to recover the significantly higher raw material costs absorbed in the first half of the year. Even as market conditions become more difficult, we will maintain our commitment to pricing discipline.”

1


 

Mr. McDonnell continued, “We also remain committed to improving our profitability through aggressive productivity and cost reduction initiatives. During the third quarter, through the significant efforts of our Pregis management and employees, we realized savings of close to $5 million from these programs. Given the very weak general economic conditions within which we are currently operating, including the possibility of a recession in the U.S. and further worldwide economic slowdown, we expect the next few quarters to be challenging. As a result, we are diligently working to identify additional cost reduction opportunities to help mitigate the impact of the weakened economic environment and drive long-term sustainable profit growth.”
For the nine months ended September 30, 2008, net sales grew to $799.7 million, higher by 10.2% compared to net sales of $725.7 million for the comparable 2007 period. Excluding the impact of favorable foreign currency translation and sales from two acquisitions made in the second half of 2007, net sales for the nine months of 2008 were relatively flat compared to the prior year period. Gross profit margin percentage declined to 21.9% for the 2008 nine month period compared to 24.6% for the 2007 period, primarily due to increased costs of resin, fuel and other raw materials, partially offset by the impact from the Company’s cost reduction initiatives.
For the nine month period, operating income was $25.6 million compared to $41.1 million for same period of 2007, with the reduction driven primarily by higher raw material costs as well as pre-tax severance charges totaling $7.8 million relating to its productivity and cost reduction initiatives. The Company expects to incur additional restructuring charges of approximately $3.3 million over the remainder of 2008 and through the first half of 2009 to complete implementation of these initiatives. Combined with the overhead optimization efforts started at the end of 2007, these programs are currently expected to generate annual savings in excess of $25 million.
Segment Performance
Comments on segment net sales performance for the third quarter of 2008 are as follows:
    Net sales of the protective packaging segment increased by $13.9 million, or 8.8%. The 2008 third quarter sales growth was driven by favorable foreign currency translation, as well as the incremental sales generated by the Besin entity acquired in the fourth quarter of 2007. The segment also achieved pricing improvement in its U.S. and European operations, which more than offset the volume declines attributed to the weakened economic conditions in these markets. Excluding the impacts of favorable foreign currency effects and revenue growth from acquisitions, net sales for the segment increased 2.6%.
 
    Net sales of the flexible packaging segment increased $4.2 million, or 9.4%. The increase was driven by favorable foreign currency translation and favorable pricing, partially offset by lower volumes due mainly to weaker economic conditions in Germany, the segment’s principal market. Excluding the impact of favorable foreign currency, the segment’s 2008 third quarter net sales were relatively flat compared to the prior year period.

2


 

    Net sales of the hospital supplies segment increased $2.0 million, or 10.5%, driven by growth in procedure packs as well as the segment’s geographic expansion efforts, partially offset by price erosion resulting from the competitive market environment. Excluding the impact of favorable foreign currency, the segment’s 2008 third quarter net sales were relatively flat compared to the prior year period.
 
    Net sales of the rigid packaging segment decreased nominally by $0.1 million. Excluding the impact of unfavorable foreign currency effects in the quarter, net sales for the segment increased 6.1% in the quarter, due mainly to higher sales volume of films and thermoformed products, partially offset by price erosion resulting from the competitive market environment.
A summary of a significant measure required by the Company’s indentures is presented in the supplemental information at the end of this release.
Conference Call:
The Company will conduct an investor conference call to review its 2008 third quarter results on Friday, November 14, 2008 at 10:00 a.m. ET (9:00 a.m. CT). The call can be accessed through the following dial-in numbers: Domestic: 800-591-6942; International: 617-614-4909; Participant Passcode: 68623125. A replay of the conference call will be available through November 28, 2008. The replay may be accessed using the following dial-in information: Domestic: 888-286-8010; International: 617-801-6888; Passcode: 92661107.
About Pregis:
Pregis Corporation is a leading global provider of innovative protective, flexible, and foodservice packaging and hospital supply products. The specialty-packaging leader currently operates 47 facilities in 18 countries around the world. Pregis Corporation is a wholly owned subsidiary of Pregis Holding II Corporation. For more information about Pregis, visit the Company’s web site at www.pregis.com.
Safe Harbor Statement:
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended. You can generally identify forward-looking statements by the Company’s use of forward-looking terminology such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “potential,” “predict,” “seek,” “should,” or “will,” or the negative thereof or other variations thereon or comparable terminology. These forward-looking statements are only predictions and involve known and unknown risks and uncertainties, many of which are beyond the Company’s control. For a discussion of key risk factors, please see the risk factors disclosed in the Company’s filings with the Securities & Exchange Commission, including the Company’s annual report on Form 10-K and quarterly reports on Form 10-Q. These risks may cause actual results, performance or achievements to differ materially from any future results, performance or achievements expressed or implied by these forward-looking statements. Given these risk and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements included in this press release are made only as of the date hereof. The Company undertakes no duty to update its forward-looking statements.

3


 

Pregis Holding II Corporation
Consolidated Balance Sheets
Unaudited

(dollars in thousands, except shares and per share data)
                 
    September 30, 2008     December 31, 2007  
    (Unaudited)          
Assets
               
Current assets
               
Cash and cash equivalents
  $ 30,038     $ 34,989  
Accounts receivable
               
Trade, net of allowances of $5,366 and $5,313, respectively
    157,467       148,045  
Other
    12,756       18,532  
Inventories, net
    114,546       108,914  
Deferred income taxes
    2,971       2,991  
Due from Pactiv
    607       7,072  
Prepayments and other current assets
    9,073       9,187  
 
           
Total current assets
    327,458       329,730  
Property, plant and equipment, net
    257,777       277,398  
Other assets
               
Goodwill
    148,414       150,000  
Intangible assets, net
    43,592       47,910  
Deferred financing costs, net
    8,328       10,080  
Due from Pactiv, long-term
    13,208       12,229  
Pension and related assets
    25,155       25,659  
Other
    431       2,313  
 
           
Total other assets
    239,128       248,191  
 
           
Total assets
  $ 824,363     $ 855,319  
 
           
Liabilities and stockholder’s equity
               
Current liabilities
               
Current portion of long-term debt
  $ 2,125     $ 2,120  
Accounts payable
    104,326       100,326  
Accrued income taxes
    7,880       13,900  
Accrued payroll and benefits
    16,953       19,814  
Accrued interest
    11,437       6,775  
Other
    25,462       22,436  
 
           
Total current liabilities
    168,183       165,371  
 
               
Long-term debt
    465,804       475,604  
Deferred income taxes
    32,342       34,589  
Long-term income tax liabilities
    10,780       9,585  
Pension and related liabilities
    8,658       9,389  
Other
    7,006       7,124  
Stockholder’s equity:
               
Common stock — $ 0.01 par value; 1,000 shares authorized, 149.0035 shares issued and outstanding at September 30, 2008 and December 31, 2007
           
Additional paid-in capital
    150,337       149,659  
Accumulated deficit
    (37,391 )     (16,588 )
Accumulated other comprehensive income
    18,644       20,586  
 
           
Total stockholder’s equity
    131,590       153,657  
 
           
Total liabilities and stockholder’s equity
  $ 824,363     $ 855,319  
 
           

4


 

Pregis Holding II Corporation
Consolidated Statements of Operations
Unaudited

(dollars in thousands)
                                 
    Three Months Ended September 30,     Nine Months Ended September 30,  
    2008     2007     2008     2007  
 
                               
Net sales
  $ 265,188     $ 245,163     $ 799,726     $ 725,710  
 
                               
Operating costs and expenses:
                               
Cost of sales, excluding depreciation and amortization
    205,673       188,426       624,443       547,258  
Selling, general and administrative
    31,232       32,793       100,407       97,489  
Depreciation and amortization
    13,584       14,242       40,734       40,736  
Other operating expense (income), net
    4,601       (656 )     8,500       (840 )
 
                       
Total operating costs and expenses
    255,090       234,805       774,084       684,643  
 
                       
 
                               
Operating income
    10,098       10,358       25,642       41,067  
Interest expense
    13,392       11,656       37,293       34,777  
Interest income
    (92 )     (465 )     (518 )     (897 )
Foreign exchange loss (gain), net
    9,562       (1,805 )     6,641       (3,527 )
 
                       
Income (loss) before income taxes
    (12,764 )     972       (17,774 )     10,714  
Income tax expense (benefit)
    (802 )     1,535       3,029       8,204  
 
                       
Net income (loss)
  $ (11,962 )   $ (563 )   $ (20,803 )   $ 2,510  
 
                       

5


 

Pregis Holding II Corporation
Consolidated Statements of Cash Flows
Unaudited

(dollars in thousands)
                 
    Nine Months Ended September 30,  
    2008     2007  
Operating activities
               
Net income (loss)
  $ (20,803 )   $ 2,510  
Adjustments to reconcile net income (loss) to cash provided by operating activities:
               
Depreciation and amortization
    40,734       40,736  
Deferred income taxes
    (1,419 )     713  
Unrealized foreign exchange loss (gain)
    6,814       (3,254 )
Amortization of deferred financing costs
    1,781       1,636  
Loss (gain) on disposal of property, plant and equipment
    (246 )     (51 )
Stock compensation expense
    678       334  
Impairment of interest rate swap asset
    1,299        
Gain on insurance settlement
          (884 )
Changes in operating assets and liabilities, net of effects of acquisitions:
               
Accounts and other receivables, net
    (12,024 )     (14,384 )
Due from Pactiv
    6,630       9,202  
Inventories, net
    (9,738 )     (14,249 )
Prepayments and other current assets
    (143 )     1,381  
Accounts payable
    7,568       15,336  
Accrued taxes
    (4,778 )     (1,551 )
Accrued interest
    4,577       5,011  
Other current liabilities
    1,871       1,027  
Pension and related assets and liabilities, net
    (2,815 )     (153 )
Other, net
    177       (2,994 )
 
           
Cash provided by operating activities
    20,163       40,366  
 
           
 
               
Investing activities
               
Capital expenditures
    (25,270 )     (23,162 )
Proceeds from sale of assets
    1,042       382  
Acquisition of business, net of cash acquired
          (8,898 )
Insurance proceeds
    1,868       884  
Other, net
    (593 )     (35 )
 
           
Cash used in investing activities
    (22,953 )     (30,829 )
 
           
 
               
Financing activities
               
Repayment of long-term debt
    (1,435 )     (1,360 )
Other, net
    62       300  
 
           
Cash used in financing activities
    (1,373 )     (1,060 )
Effect of exchange rate changes on cash and cash equivalents
    (788 )     2,748  
 
           
Increase (decrease) in cash and cash equivalents
    (4,951 )     11,225  
Cash and cash equivalents, beginning of period
    34,989       45,667  
 
           
Cash and cash equivalents, end of period
  $ 30,038     $ 56,892  
 
           

6


 

Pregis Holding II Corporation
Supplemental Information
(Unaudited)
Calculation of Adjusted EBITDA (“Consolidated Cash Flow”)
                 
    Twelve Months Ended September 30,  
(dollars in thousands)   2008     2007  
 
               
Net loss of Pregis Holding II Corporation
  $ (28,092 )   $ (3,553 )
Interest expense, net of interest income
    48,300       44,818  
Income tax expense
    2,533       11,801  
Depreciation and amortization
    55,797       54,717  
 
           
EBITDA
    78,538       107,783  
 
               
Other non-cash charges (income):
               
Unrealized foreign currency transaction losses (gains), net
    7,846       (6,109 )
Non-cash stock based compensation expense
    902       269  
Non-cash asset impairment charge
    403        
Other non-cash expenses, primarily fixed asset disposals and write-offs
    427        
Net unusual or nonrecurring gains or losses:
               
Restructuring, severance and related expenses
    12,409       5,051  
Nonrecurring charges related to acquisitions and dispositions
    4,512       3,044  
Other unusual or nonrecurring gains or losses
    123       792  
Other adjustments:
               
Amounts paid pursuant to management agreement with Sponsor
    1,834       1,802  
Pro forma earnings and costs savings
    454       1,480  
 
           
 
               
Adjusted EBITDA (“Consolidated Cash Flow”)
  $ 107,448     $ 114,112  
 
           
Note to above:
EBITDA is defined as net income before interest expense, interest income, income tax expense, depreciation and amortization. Adjusted EBITDA, referred to as Consolidated Cash Flow within the context of the Company’s indentures, is presented herein because it is a material element of the fixed charge coverage ratio and secured indebtedness leverage ratio included in the Company’s indentures.

7


 

Pregis Holding II Corporation
Third Quarter 2008
Supplemental Information
(Unaudited)

(Amounts and percentage changes are approximations due to rounding.)
Gross Margin Calculations
                                                 
    Three Months Ended September 30,     Nine Months Ended September 30,  
(dollars in millions)   2008     2007     Change     2008     2007     Change  
 
                                               
Net sales
  $ 265.2     $ 245.2     $ 20.0     $ 799.7     $ 725.7     $ 74.0  
Cost of sales, excluding depreciation and amortization
    (205.7 )     (188.5 )     (17.2 )     (624.4 )     (547.3 )     (77.1 )
 
                                   
Gross margin
  $ 59.5     $ 56.7     $ 2.8     $ 175.3     $ 178.4     $ (3.1 )
 
                                   
Gross margin, as a percent of net sales
    22.4 %     23.1 %     (0.7 )%     21.9 %     24.6 %     (2.7 )%
 
                                   
Net Sales Analysis by Segment
                                                                 
                                    Change Attributable to the Following Factors  
    Three Months Ended September 30,                     Price /                     Currency  
(dollars in millions)   2008     2007     $ Change     % Change     Mix     Volume     Acquisitions     Translation  
 
                                                               
Segment:
                                                               
Protective Packaging
  $ 172.1     $ 158.2     $ 13.9       8.8 %     5.5 %     (2.9 )%     3.9 %     2.3 %
Flexible Packaging
    48.9       44.7       4.2       9.4 %     3.7 %     (3.0 )%           8.7 %
Hospital Supplies
    20.7       18.7       2.0       10.5 %     (1.4 )%     2.2 %           9.7 %
Rigid Packaging
    25.2       25.3       (0.1 )     (0.6 )%     (1.8 )%     7.9 %           (6.7 )%
Intersegment eliminations
    (1.7 )     (1.7 )                                              
 
                                                         
Total
  $ 265.2     $ 245.2     $ 20.0       8.2 %     3.9 %     (1.4 )%     2.5 %     3.2 %
 
                                                         
                                                                 
                                    Change Attributable to the Following Factors  
    Nine Months Ended September 30,                     Price /                     Currency  
(dollars in millions)   2008     2007     $ Change     % Change     Mix     Volume     Acquisitions     Translation  
 
                                                               
Segment:
                                                               
Protective Packaging
  $ 520.3     $ 469.7     $ 50.6       10.8 %     2.1 %     (1.0 )%     5.4 %     4.3 %
Flexible Packaging
    148.0       131.3       16.7       12.8 %     1.2 %     (0.6 )%           12.2 %
Hospital Supplies
    63.5       55.9       7.6       13.6 %     (2.4 )%     2.6 %           13.4 %
Rigid Packaging
    72.7       72.4       0.3       0.5 %     (1.0 )%     3.7 %           (2.2 )%
Intersegment eliminations
    (4.8 )     (3.6 )     (1.2 )                                        
 
                                                         
Total
  $ 799.7     $ 725.7     $ 74.0       10.2 %     1.3 %     (0.5 )%     3.5 %     5.9 %
 
                                                         

8